CRISPR-Cas9 technology has demonstrated enormous potential in producing more effective and tailored therapeutics for genetic illnesses. Here are some major characteristics of its application and the ethical considerations involved : 

1. Precision editing : CRISPR-Cas9 has the ability to precisely target and alter particular genes. Correcting mutations that cause genetic illnesses including sickle cell anaemia, muscular dystrophy, and cystic fibrosis is especially helpful in this regard.

2. Gene knockout : This technique allows defective genes to be turned off. For instance, slowing the progression of Huntington’s disease may be possible by deleting a gene that generates a hazardous protein.

3. Gene Insertion: The genome can contain new, functional genes inserted by CRISPR-Cas9. This method can be applied to disorders like haemophilia, in which the condition is caused by the lack of a functioning gene.

4.  Cell therapy: Using CRISPR-Cas9, a patient’s own cells can have their genomes altered outside of their bodies and then reintroduced. In diseases like leukaemia, where altered immune cells are more effective in identifying and eliminating cancer cells, this strategy is being investigated.

5. Animal Models: By producing animal models that closely resemble genetic abnormalities in humans, CRISPR-Cas9 can aid in the investigation of disease mechanisms and the creation of novel therapeutics.

Here are some ethical considerations related to this technique :

1. Gene editing in human embryos: This technique allows for the modification of genes to be passed on to subsequent generations. Concerns regarding consent, long-term repercussions, and potential misuse are raised by this, raising serious ethical issues. Most people agree that CRISPR-Cas9 should not be used for human germline editing until its safety and moral implications are thoroughly investigated.

2  Effects Off-Target: CRISPR-Cas9 occasionally cuts DNA at locations that aren’t intended, which could result in dangerous mutations. Before the technology is extensively applied to human therapeutics, it must be ensured that it is safe and targeted.

3. Equity and Access: The cost and accessibility of advanced genetic medicines may prevent many people from using them, which would worsen health inequities. Ensuring fair and equal access to these medicines is a crucial ethical factor.

4. Regulation and Oversight: To supervise the application of CRISPR-Cas9 in clinical settings, strong regulatory frameworks are required. This includes long-term patient monitoring following gene editing procedures, safety regulations, and ethical considerations.

To sum up, CRISPR-Cas9 has a lot of potential for more accurately and successfully treating genetic illnesses. Nevertheless, the use of nanotechnology on people needs to be done very carefully, taking into account the serious ethical and safety issues as well as any potential advantages.